Skip to content

Tetrazepam

MUSCULO-SKELETAL SYSTEM

Also known as: myolastan

ATC M03BX07

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Tetrazepam is a drug catalogued in DrugCentral.

  • ATC code: M03BX07 (Other centrally acting agents).
  • Molecular formula: C16H17ClN2O; molecular weight 288.78 g/mol.

ATC classification

ATC codeTherapeutic hierarchy
M03BX07MUSCULO-SKELETAL SYSTEM › MUSCLE RELAXANTS › MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS › Other centrally acting agents

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Logorrhoea98.0
Transposition of the great vessels93.8
Toxicity to various agents90.9
Cross sensitivity reaction86.4
Dermatitis contact81.5
Vestibular disorder65.4
Eczema eyelids58.4
Skin test positive55.8
Occupational exposure to product55.0
Disturbance in attention53.5
Ventricular septal defect52.2
Agoraphobia48.0

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Tetrazepam is on its molecule page.

Molecular formulaC16H17ClN2O
Molecular weight288.78 g/mol
CAS number10379-14-3
InChIKeyIQWYAQCHYZHJOS-UHFFFAOYSA-N
PubChem CID25215
CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CCCCC1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is the chemical formula of Tetrazepam?

Tetrazepam has the molecular formula C16H17ClN2O and a molecular weight of 288.78 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets0
Indications0
FormulaC16H17ClN2O
DrugCentral ID2614
Interactive profile